Oncology Topics

Samsung Biologics has further expanded its partnership with STCube through an additional development and manufacturing service agreement of STM418, an anti-PD1 immuno-oncology candidate.STM418 received much attention from the biopharma industry earlier this year upon pu.. Read the news

OmniSeq®, an innovator in next generation sequencing (NGS) in oncology, today announced the benefits of its OmniSeq Advance® comprehensive genomic and immune profiling assay to detect the presence of rare alterations in the RET gene in the tumors of some patients w.. Read the news

Sutro Biopharma, Inc, a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, announced updated interim data regarding safety an.. Read the news

ArcherDX, Inc., announced that its ArcherMET companion diagnostic (CDx) has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceutical Medical Devices Agency (PMDA) to detect MET exon 14 (METex14) skipping alterations in tissue .. Read the news

The increasing cost of medicine for consumers of the U.S. came back in focus in 2018, as soon as President Trump’s government revealed an extensive policy proposal challenging drug prices, facilitating to reignite the deliberation over the amount patients are paying f.. Read the news

The key factors such as increasing prevalence of cancer across the globe, growing generic drug launches and benefits offered by the generic drugs are likely to boost the market growth, whereas, inclination towards the personalized medicine for cancer is likely to be a p.. Read the news